Literature DB >> 2201346

Methods for antagonizing glutamate neurotoxicity.

D W Choi1.   

Abstract

Recent evidence suggests that glutamate-induced neuronal damage may contribute importantly to neuronal death in several neurological diseases, including cerebral hypoxia-ischemia. This review outlines a range of measures that might be used to protect neurons from such excitotoxic damage. The organizing thesis is a speculative consideration of glutamate neurotoxicity as a sequential three-stage process--induction, amplification, and expression--each perhaps specifically amenable to therapeutic interference. Overstimulation of glutamate receptors likely induces the intracellular accumulation of several substances, including Ca2+, Na+, inositol-1,4,5-trisphosphate, and diacylglycerol. Blockade of this induction might be accomplished most easily by antagonizing postsynaptic glutamate receptors, but also might be accomplished by reducing glutamate release from presynaptic terminals, or improving glutamate clearance from synaptic clefts. Following induction, several steps may importantly amplify the resultant rise in intracellular free Ca2+, and promote the spread of excessive excitation to other circuit neurons. Protective strategies operative at this level might include blockade of additional Ca2+ influx, blockade of Ca2+ release from intracellular stores, and interference with the mechanisms coupling glutamate receptor stimulation to lasting enhancements of excitatory synaptic efficacy. Following amplification, toxic levels of intracellular free Ca2+ might trigger destructive cascades bearing direct responsibility for resultant neuronal degeneration--the expression of excitotoxicity. The most important cascades to block may be those related to the activation of catabolic enzymes, and the generation of free radicals. Broad consideration of possible methods for antagonizing glutamate neurotoxicity may be needed to develop therapies with the greatest efficacy, and least adverse consequences for brain function.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2201346

Source DB:  PubMed          Journal:  Cerebrovasc Brain Metab Rev        ISSN: 1040-8827


  44 in total

Review 1.  Autoradiographic assessment of the effects of N-methyl-D-aspartate (NMDA) receptor antagonists in vivo.

Authors:  J McCulloch; L L Iversen
Journal:  Neurochem Res       Date:  1991-09       Impact factor: 3.996

Review 2.  Lipids and lipidomics in brain injury and diseases.

Authors:  Rao Muralikrishna Adibhatla; J F Hatcher; R J Dempsey
Journal:  AAPS J       Date:  2006-05-05       Impact factor: 4.009

3.  The effect of global brain ischemia in normal and diabetic animals: the influence of calcium channel blockers.

Authors:  Joseph Levy; Zhengxian Zhu; Joseph C Dunbar
Journal:  Endocrine       Date:  2004-11       Impact factor: 3.633

Review 4.  Blockade of glutamate excitotoxicity and its clinical applications.

Authors:  K Hirose; P H Chan
Journal:  Neurochem Res       Date:  1993-04       Impact factor: 3.996

5.  In vitro neuroprotection against oxidative stress by pre-treatment with a combination of dihydrolipoic acid and phenyl-butyl nitrones.

Authors:  Michael L Koenig; James L Meyerhoff
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

6.  Enhanced sensitivity of hippocampal pyramidal neurons from mdx mice to hypoxia-induced loss of synaptic transmission.

Authors:  M F Mehler; K Z Haas; J A Kessler; P K Stanton
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

7.  Adenosine influences the high-affinity uptake of transmitter glutamate and aspartate under conditions of hepatic encephalopathy.

Authors:  W Schmidt; G Wolf; K Grüngreiff; K Linke
Journal:  Metab Brain Dis       Date:  1993-06       Impact factor: 3.584

8.  Effects of transforming growth factor-beta on murine astrocyte glutamine synthetase activity. Implications in neuronal injury.

Authors:  C C Chao; S Hu; M Tsang; J Weatherbee; T W Molitor; W R Anderson; P K Peterson
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

9.  Molecular basis of vitamin E action: tocotrienol modulates 12-lipoxygenase, a key mediator of glutamate-induced neurodegeneration.

Authors:  Savita Khanna; Sashwati Roy; Hoon Ryu; Praveen Bahadduri; Peter W Swaan; Rajiv R Ratan; Chandan K Sen
Journal:  J Biol Chem       Date:  2003-08-13       Impact factor: 5.157

10.  The neuroprotective effect of a nitric oxide inhibitor in a rat model of focal cerebral ischaemia.

Authors:  A Buisson; M Plotkine; R G Boulu
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.